Capricor Therapeutics, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before September 15, 2025 to Discuss Your Rights - CAPR - Capricor Therapeutics ( NASDAQ:CAPR )
NEW YORK, Aug. 22, 2025 ( GLOBE NEWSWIRE ) -- Levi & Korsinsky, LLP notifies investors in Capricor Therapeutics, Inc. ( "Capricor" or the "Company" ) CAPR of a class action securities lawsuit.
Why Is Biohaven Stock Soaring Friday? - Biohaven ( NYSE:BHVN )
The FDA has cancelled the advisory meeting for Biohaven's SCA drug application. NDA decision for troriluzole expected in the fourth quarter of 2025. See the seasonal trading strategy that's beating the S&P 500 by 6X this year. Details here → Biohaven Ltd.
ROSEN, A TOP RANKED LAW FIRM, Encourages Capricor Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CAPR - Capricor Therapeutics ( NASDAQ:CAPR )
NEW YORK, Aug. 21, 2025 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Capricor Therapeutics, Inc. CAPR between October 9, 2024 and July 10, 2025, both dates inclusive ( the "Class Period" ) , of the important September 15, ...
CAPR LAWSUIT ALERT: The Gross Law Firm Notifies Capricor Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - Capricor Therapeutics ( NASDAQ:CAPR )
NEW YORK, Aug. 21, 2025 ( GLOBE NEWSWIRE ) -- The Gross Law Firm issues the following notice to shareholders of Capricor Therapeutics, Inc. CAPR. Shareholders who purchased shares of CAPR during the class period listed are encouraged to contact the firm regarding possible lead plaintiff ...
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Capricor Therapeutics, Inc. - CAPR - Capricor Therapeutics ( NASDAQ:CAPR )
NEW YORK, Aug. 21, 2025 ( GLOBE NEWSWIRE ) -- Pomerantz LLP is investigating claims on behalf of investors of Capricor Therapeutics, Inc. ( "Capricor" or the "Company" ) CAPR. Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of September 15, 2025 in Capricor Therapeutics, Inc. Lawsuit - CAPR - Capricor Therapeutics ( NASDAQ:CAPR )
NEW YORK, Aug. 19, 2025 ( GLOBE NEWSWIRE ) -- Levi & Korsinsky, LLP notifies investors in Capricor Therapeutics, Inc. ( "Capricor" or the "Company" ) CAPR of a class action securities lawsuit.
Capricor Therapeutics, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. September 15, 2025 Deadline to file Lead Plaintiff Motion - Capricor Therapeutics ( NASDAQ:CAPR )
Investors can contact the law firm at no cost to learn more about recovering their losses
SHAREHOLDER ALERT: Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Capricor Therapeutics, Inc. ( NASDAQ: CAPR ) - Capricor Therapeutics ( NASDAQ:CAPR )
NEW YORK, Aug. 18, 2025 ( GLOBE NEWSWIRE ) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors ( the "Class" ) who purchased or acquired the securities of Capricor Therapeutics, Inc. ( "Capricor" or the "Company" ) CAPR ...
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Capricor Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CAPR - Capricor Therapeutics ( NASDAQ:CAPR )
NEW YORK, Aug. 16, 2025 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Capricor Therapeutics, Inc. CAPR between October 9, 2024 and July 10, 2025, both dates inclusive ( the "Class Period" ) , of the important September 15, ...
Capricor Therapeutics, Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before September 15, 2025 to Discuss Your Rights - CAPR - Capricor Therapeutics ( NASDAQ:CAPR )
NEW YORK, Aug. 13, 2025 ( GLOBE NEWSWIRE ) -- The Gross Law Firm issues the following notice to shareholders of Capricor Therapeutics, Inc. CAPR. Shareholders who purchased shares of CAPR during the class period listed are encouraged to contact the firm regarding possible lead plaintiff ...
ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Capricor Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CAPR - Capricor Therapeutics ( NASDAQ:CAPR )
NEW YORK, Aug. 13, 2025 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Capricor Therapeutics, Inc. CAPR between October 9, 2024 and July 10, 2025, both dates inclusive ( the "Class Period" ) , of the important September 15, ...
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Capricor Therapeutics, Inc. - CAPR - Capricor Therapeutics ( NASDAQ:CAPR )
NEW YORK, Aug. 13, 2025 ( GLOBE NEWSWIRE ) -- Pomerantz LLP is investigating claims on behalf of investors of Capricor Therapeutics, Inc. ( "Capricor" or the "Company" ) CAPR. Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Capricor Therapeutics - Capricor Therapeutics ( NASDAQ:CAPR )
Faruqi & Faruqi, LLP Securities Litigation Partner James ( Josh ) Wilson Encourages Investors Who Suffered Losses In Capricor To Contact Him Directly To Discuss Their Options
C3.ai, Destiny Tech100 And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Ambiq Micro ( NYSE:AMBQ ) , C3.ai ( NYSE:AI )
U.S. stock futures were mixed this morning, with the Dow futures falling around 0.1% on Monday. Shares of C3.ai, Inc. AI fell sharply in pre-market trading after the company reported preliminary first-quarter revenue of $70.2 million to $70.4 million with GAAP operating loss of up to $124.9 million.
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Capricor Therapeutics, Inc. ( NASDAQ: CAPR ) - Capricor Therapeutics ( NASDAQ:CAPR )
NEW YORK, Aug. 11, 2025 ( GLOBE NEWSWIRE ) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors ( the "Class" ) who purchased or acquired the securities of Capricor Therapeutics, Inc. ( "Capricor" or the "Company" ) CAPR ...
Why International Money Express Shares Are Trading Higher By Around 54%; Here Are 20 Stocks Moving Premarket - ALT5 Sigma ( NASDAQ:ALTS ) , C3.ai ( NYSE:AI )
Shares of International Money Express, Inc. IMXI rose sharply in pre-market trading after Western Union announced plans to acquire Intermex for $500 million. Western Union revealed its plans to acquire Intermex, a U.S.-based company specializing in payment transfers to Latin America and the ...
Class Action Filed Against Capricor Therapeutics, Inc. ( CAPR ) - September 15, 2025 Deadline to Join - Contact Levi & Korsinsky - Capricor Therapeutics ( NASDAQ:CAPR )
NEW YORK, Aug. 08, 2025 ( GLOBE NEWSWIRE ) -- Levi & Korsinsky, LLP notifies investors in Capricor Therapeutics, Inc. ( "Capricor" or the "Company" ) CAPR of a class action securities lawsuit.
Capricor Therapeutics Announces Type A Meeting Scheduled with U.S. FDA
- Second Quarter 2025 Financial Results and Corporate Update Rescheduled to Monday, August 11, 2025, at 4:30 p.m. ET - - Second Quarter 2025 Financial Results and Corporate Update Rescheduled to Monday, August 11, 2025, at 4:30 p.m. ET ...
Capricor Therapeutics Announces Type A Meeting Scheduled with U.S. FDA - Capricor Therapeutics ( NASDAQ:CAPR )
SAN DIEGO, Aug. 08, 2025 ( GLOBE NEWSWIRE ) -- Capricor Therapeutics CAPR, a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment of rare diseases, today announced that a Type A meeting with the U.S.
Quanterix Corporation ( QTRX ) Reports Q2 Loss, Misses Revenue Estimates
Quanterix (QTRX) delivered earnings and revenue surprises of -14.63% and -12.62%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Capricor Therapeutics to Present Second Quarter 2025 Financial Results and Recent Corporate Update on August 13
- Company to Host Conference Call on August 13, 2025, at 4:30 p.m. ET - - Company to Host Conference Call on August 13, 2025, at 4:30 p.m. ET ...
Levi & Korsinsky Reminds Capricor Therapeutics, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 15, 2025 - CAPR - Capricor Therapeutics ( NASDAQ:CAPR )
NEW YORK, Aug. 05, 2025 ( GLOBE NEWSWIRE ) -- Levi & Korsinsky, LLP notifies investors in Capricor Therapeutics, Inc. ( "Capricor" or the "Company" ) CAPR of a class action securities lawsuit.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Capricor Therapeutics, Inc. - CAPR - Capricor Therapeutics ( NASDAQ:CAPR )
NEW YORK, Aug. 05, 2025 ( GLOBE NEWSWIRE ) -- Pomerantz LLP is investigating claims on behalf of investors of Capricor Therapeutics, Inc. ( "Capricor" or the "Company" ) CAPR. Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
Investors in Capricor Therapeutics, Inc. Should Contact The Gross Law Firm Before September 15, 2025 to Discuss Your Rights - CAPR - Capricor Therapeutics ( NASDAQ:CAPR )
NEW YORK, Aug. 04, 2025 ( GLOBE NEWSWIRE ) -- The Gross Law Firm issues the following notice to shareholders of Capricor Therapeutics, Inc. CAPR. Shareholders who purchased shares of CAPR during the class period listed are encouraged to contact the firm regarding possible lead plaintiff ...
CAPRICOR THERAPEUTICS, INC. ( NASDAQ: CAPR ) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Capricor Therapeutics, Inc. Investors of Upcoming Deadline - Capricor Therapeutics ( NASDAQ:CAPR )
NEW YORK, Aug. 04, 2025 ( GLOBE NEWSWIRE ) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds Capricor Therapeutics, Inc. ( "Capricor" or the "Company" ) CAPR investors of an upcoming deadline involving a securities fraud class action lawsuit commenced against ...
ROSEN, A LEADING NATIONAL FIRM, Encourages Capricor Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CAPR - Capricor Therapeutics ( NASDAQ:CAPR )
NEW YORK, Aug. 03, 2025 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Capricor Therapeutics, Inc. CAPR between October 9, 2024 and July 10, 2025, both dates inclusive ( the "Class Period" ) , of the important September 15, ...
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Capricor Therapeutics - Capricor Therapeutics ( NASDAQ:CAPR )
Faruqi & Faruqi, LLP Securities Litigation Partner James ( Josh ) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Capricor To Contact Him Directly To Discuss Their Options
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Capricor Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CAPR - Capricor Therapeutics ( NASDAQ:CAPR )
NEW YORK, July 31, 2025 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Capricor Therapeutics, Inc. CAPR between October 9, 2024 and July 10, 2025, both dates inclusive ( the "Class Period" ) , of the important September 15, ...
Contact Levi & Korsinsky by September 15, 2025 Deadline to Join Class Action Against Capricor Therapeutics, Inc. ( CAPR ) - Capricor Therapeutics ( NASDAQ:CAPR )
NEW YORK, July 31, 2025 ( GLOBE NEWSWIRE ) -- Levi & Korsinsky, LLP notifies investors in Capricor Therapeutics, Inc. ( "Capricor" or the "Company" ) CAPR of a class action securities lawsuit.
What's Going On With Sarepta, Capricor And Other Gene Therapy Stocks On Wednesday? - Sarepta Therapeutics ( NASDAQ:SRPT ) , Capricor Therapeutics ( NASDAQ:CAPR )
After three months amid political and public pressure, Vinay Prasad resigns from the FDA's biologics center. FDA reversed Sarepta's Elevidys shipment halt just a day before Prasad's abrupt exit. The market's back, and these 3 income stocks are thriving. See them here→
Why LendingClub Shares Are Trading Higher By Around 23%; Here Are 20 Stocks Moving Premarket - Antelope Ent Hldgs ( NASDAQ:AEHL ) , AtriCure ( NASDAQ:ATRC )
Shares of LendingClub Corporation LC rose sharply in pre-market trading after the company reported better-than-expected second-quarter sales results. LendingClub reported a strong second-quarter performance, with a 156% increase in net income.
Class Action Filed Against Capricor Therapeutics, Inc. ( CAPR ) - September 15, 2025 Deadline to Join - Contact Levi & Korsinsky - Capricor Therapeutics ( NASDAQ:CAPR )
NEW YORK, July 28, 2025 ( GLOBE NEWSWIRE ) -- Levi & Korsinsky, LLP notifies investors in Capricor Therapeutics, Inc. ( "Capricor" or the "Company" ) CAPR of a class action securities lawsuit.
ROSEN, TOP RANKED NATIONAL INVESTOR ATTORNEYS, Encourages Capricor Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CAPR
ROSEN, TOP RANKED NATIONAL INVESTOR ATTORNEYS, Encourages Capricor Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action ...
Faruqi & Faruqi Reminds Shareholders of a Lead Plaintiff Deadline of September 15, 2025 in Capricor Lawsuit - CAPR
Faruqi & Faruqi Reminds Shareholders of a Lead Plaintiff Deadline of September 15, 2025 in Capricor Lawsuit ...
CAPR Class Action Alert: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Capricor Therapeutics, Inc. Securities Class Action - Capricor Therapeutics ( NASDAQ:CAPR )
SAN DIEGO, July 25, 2025 ( GLOBE NEWSWIRE ) -- Robbins LLP reminds stockholders that a class action was filed on behalf of investors who purchased or otherwise acquired Capricor Therapeutics, Inc. CAPR securities between October 9, 2024 and July 10, 2025.
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Capricor Therapeutics - Capricor Therapeutics ( NASDAQ:CAPR )
Faruqi & Faruqi, LLP Securities Litigation Partner James ( Josh ) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Capricor To Contact Him Directly To Discuss Their Options
Bragar Eagel & Squire, P.C. Urges Investors in XPLR Infrastructure, Centene, Biohaven, or Capricor to Inquire About Their Rights in Class Action Lawsuits - Biohaven ( NYSE:BHVN ) , Capricor Therapeutics ( NASDAQ:CAPR )
If you purchased or acquired securities in any of the above companies during their class period and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directly at ( 212 ) 355-4648
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Capricor Therapeutics, Inc. ( CAPR ) Shareholders - Capricor Therapeutics ( NASDAQ:CAPR )
NEW YORK, July 22, 2025 ( GLOBE NEWSWIRE ) -- Levi & Korsinsky, LLP notifies investors in Capricor Therapeutics, Inc. ( "Capricor" or the "Company" ) CAPR of a class action securities lawsuit.
ROSEN, LEADING INVESTOR COUNSEL, Encourages Capricor Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CAPR - Capricor Therapeutics ( NASDAQ:CAPR )
NEW YORK, July 22, 2025 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Capricor Therapeutics, Inc. CAPR between October 9, 2024 and July 10, 2025, both dates inclusive ( the ...
Important Notice to Long-Term Shareholders of Capricor Therapeutics, Inc. ( NASDAQ: CAPR ) ; Centene Corporation ( NYSE: CNC ) ; DoubleVerify Holdings, Inc. ( NYSE: DV ) ; and Treace Medical Concepts, Inc. ( NASDAQ: TMCI ) ; Grabar Law Office is Investigating Claims on Your Behalf - Centene ( NYSE:CNC ) , Capricor Therapeutics ( NASDAQ:CAPR )
PHILADELPHIA, July 21, 2025 ( GLOBE NEWSWIRE ) -- Grabar Law Office is investigating claims on behalf of shareholders of Capricor Therapeutics, Inc. CAPR. The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Capricor Therapeutics
Faruqi & Faruqi, LLP Securities Litigation Partner James ( Josh ) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Capricor To Contact Him Directly To Discuss Their Options
CAPRICOR ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Capricor Therapeutics, Inc. and Encourages Investors to Contact the Firm - Capricor Therapeutics ( NASDAQ:CAPR )
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Capricor ( CAPR ) To Contact Him Directly To Discuss Their Options
CAPR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Capricor Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - Capricor Therapeutics ( NASDAQ:CAPR )
NEW YORK, July 18, 2025 ( GLOBE NEWSWIRE ) -- Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Capricor Therapeutics, Inc. ( "Capricor" or "the Company" ) CAPR and certain of its ...
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Capricor Therapeutics - Capricor Therapeutics ( NASDAQ:CAPR )
Faruqi & Faruqi, LLP Securities Litigation Partner James ( Josh ) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Capricor To Contact Him Directly To Discuss Their Options
CAPRICOR THERAPEUTICS, INC. ( NASDAQ: CAPR ) INVESTOR ALERT: Investors With Large Losses in Capricor Therapeutics, Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights - Capricor Therapeutics ( NASDAQ:CAPR )
Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors ( the "Class" ) who purchased or acquired the securities of Capricor Therapeutics, Inc. ( "Capricor" or the "Company" ) CAPR between October 9, 2024 and July 10, 2025, inclusive.
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Capricor Therapeutics, Inc. ( CAPR ) - Capricor Therapeutics ( NASDAQ:CAPR )
NEW YORK, July 18, 2025 ( GLOBE NEWSWIRE ) -- Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the Southern District of California on behalf of all persons or entities who purchased or otherwise acquired Capricor ...
Shareholder Alert: Robbins LLP Informs Investors of the Capricor Therapeutics, Inc. Class Action - Capricor Therapeutics ( NASDAQ:CAPR )
SAN DIEGO, July 17, 2025 ( GLOBE NEWSWIRE ) -- Robbins LLP informs stockholders that a class action was filed on behalf of investors who purchased or otherwise acquired Capricor Therapeutics, Inc. CAPR securities between October 9, 2024 and July 10, 2025.
INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of Capricor Therapeutics, Inc. ( CAPR ) Investors - Holzer & Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm - Capricor Therapeutics ( NASDAQ:CAPR )
ATLANTA, July 17, 2025 ( GLOBE NEWSWIRE ) -- A shareholder class action lawsuit has been filed Capricor Therapeutics, Inc. ( "Capricor" or the "Company" ) CAPR. The lawsuit alleges that Defendants made materially false and/or misleading statements and/or failed to disclose material adverse ...
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors It Has Filed a Complaint to Recover Losses Suffered by Purchasers of Capricor Therapeutics, Inc. Securities and Sets a Lead Plaintiff Deadline of September 15, 2025 - Capricor Therapeutics ( NASDAQ:CAPR )
NEW YORK, July 17, 2025 ( GLOBE NEWSWIRE ) -- The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Capricor Therapeutics, Inc. ( "Capricor" or the "Company" ) CAPR between October 9, 2024 and July 10, ...
BREAKING: Capricor Therapeutics Sued For Securities Fraud; Investors Should Contact Block & Leviton to Potentially Recover Losses - Capricor Therapeutics ( NASDAQ:CAPR )
BOSTON, July 17, 2025 ( GLOBE NEWSWIRE ) -- Block & Leviton announces that a securities fraud lawsuit has been filed against Capricor Therapeutics, Inc. CAPR and certain of its executives.
